Skip to main content
Xvivo Perfusion logo

Xvivo Perfusion — Investor Relations & Filings

Ticker · XVIVO ISIN · SE0004840718 LEI · 549300G2464FYLS14B41 ST Manufacturing
Filings indexed 286 across all filing types
Latest filing 2023-04-24 Interim / Quarterly Rep…
Country SE Sweden
Listing ST XVIVO

About Xvivo Perfusion

https://www.xvivogroup.com/

Xvivo Perfusion is a medical technology company specializing in ex-vivo organ preservation for transplantation. The company develops machine perfusion technologies, solutions, and services designed to extend the life of major organs, including lungs, livers, and kidneys. Its core technology, organ perfusion, is an alternative to static cold storage that continuously supplies an organ with an oxygenated solution while it is outside the body. This process helps support cellular function, prevent tissue damage, and allows clinicians to assess organ viability prior to transplant. The company's objective is to increase organ utilization, extend preservation times, and improve patient outcomes. Key products include the XPS™ for lung perfusion, Liver Assist™, Kidney Assist Transport™, and the PERFADEX® Plus solution for lung preservation.

Recent filings

Filing Released Lang Actions
Interim / Quarterly Report 2023
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Interim report January – March 2023' and contains comprehensive financial statements, key ratios, management commentary, and business performance analysis for the first quarter of 2023. It is a substantive financial report rather than a short announcement or certification, fitting the definition of an Interim/Quarterly Report. Q1 2023
2023-04-24 English
Annual Report (ESEF) 2022
Annual Report (ESEF) Classification · 100% confidence FY 2022
2023-04-03 Swedish
Annual Report (ESEF) 2022
Annual Report (ESEF) Classification · 100% confidence FY 2022
2023-04-03 Swedish
Interim / Quarterly Report 2022
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Bokslutskommuniké 2022' (Year-end Report 2022) for XVIVO Perfusion AB. It contains comprehensive financial statements, including income statements, cash flow data, and detailed management commentary on performance for the fourth quarter and the full fiscal year 2022. It is a substantive financial report rather than a brief announcement or a regulatory certification, fitting the definition of an Interim/Quarterly Report (IR) as it covers the final period of the fiscal year. Q4 2022
2023-01-26 Swedish
Interim / Quarterly Report 2022
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Report on Operations 2022' for XVIVO Perfusion AB. It provides detailed quarterly (Q4) and full-year financial results, including net sales, EBITDA, EBIT, cash flow, and earnings per share, along with management commentary and operational highlights. It contains substantive financial data and analysis for a period shorter than a full fiscal year (Q4) and the full year, fitting the definition of an Interim/Quarterly Report. It is not a mere announcement (RPA) as it contains the full financial tables and management discussion. FY 2022
2023-01-26 English
Ökat antal aktier och röster i XVIVO Perfusion AB (publ)
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a short announcement dated December 30, 2022, stating that the total number of shares and votes in XVIVO Perfusion AB has increased due to a directed new share issue announced previously. This directly relates to a change in the company's capital structure (share count). This aligns best with the 'Share Issue/Capital Change' definition (SHA). Although it is a regulatory announcement, the specific nature of the content points more strongly to SHA than the general 'RNS' fallback. The document length is short (1567 chars) and it announces a specific corporate action regarding shares.
2022-12-30 Swedish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.